Clinical Trials Browser

Phase 2 × Has results × pidilizumab × Clear all

NCT01313416 2019-07-10

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01420965 2019-07-10

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer

Phase 2 Terminated

7 enrolled 7 charts

Prostatic Neoplasms

NCT02530125 2018-03-19

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

Phase 2 Terminated

4 enrolled 8 charts

Lymphoma, Large B-Cell, Diffuse

NCT01441765 2017-02-08

PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine

Phase 2 Terminated

11 enrolled 6 charts

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00904722 2016-06-03

Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma

Phase 2 Completed

32 enrolled 4 charts

Lymphoma, Lymphoma, Follicular

NCT00532259 2014-09-12

CT-011 MAb in DLBCL Patients Following ASCT

Phase 2 Completed

72 enrolled 9 charts

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse